Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$211.93 - $241.33 $188,193 - $214,301
888 Added 14.63%
6,958 $1.68 Million
Q1 2023

May 08, 2023

BUY
$213.32 - $257.83 $203,293 - $245,711
953 Added 18.62%
6,070 $1.39 Million
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $82,914 - $101,330
407 Added 8.64%
5,117 $1.2 Million
Q3 2022

Nov 07, 2022

BUY
$204.81 - $262.19 $26,010 - $33,298
127 Added 2.77%
4,710 $964,000
Q2 2022

Aug 10, 2022

SELL
$213.86 - $277.87 $61,805 - $80,304
-289 Reduced 5.93%
4,583 $1.07 Million
Q1 2022

May 12, 2022

SELL
$259.82 - $298.18 $48.3 Million - $55.4 Million
-185,761 Reduced 97.44%
4,872 $1.28 Million
Q4 2021

Feb 11, 2022

BUY
$271.6 - $314.21 $81,751 - $94,577
301 Added 0.16%
190,633 $59.7 Million
Q3 2021

Nov 10, 2021

SELL
$274.82 - $308.34 $572,999 - $642,888
-2,085 Reduced 1.08%
190,332 $53.6 Million
Q2 2021

Aug 11, 2021

BUY
$251.87 - $278.14 $46.4 Million - $51.3 Million
184,355 Added 2286.72%
192,417 $53.1 Million
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $1.65 Million - $2.06 Million
8,062 New
8,062 $2.04 Million
Q4 2020

Feb 12, 2021

SELL
$186.91 - $214.42 $1.56 Million - $1.78 Million
-8,323 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $2.02 Million - $2.44 Million
-12,104 Reduced 59.25%
8,323 $1.55 Million
Q2 2020

Aug 12, 2020

SELL
$113.31 - $182.44 $55,635 - $89,578
-491 Reduced 2.35%
20,427 $3.31 Million
Q1 2020

May 11, 2020

SELL
$104.32 - $195.28 $259,756 - $486,247
-2,490 Reduced 10.64%
20,918 $2.64 Million
Q4 2019

Feb 07, 2020

SELL
$163.48 - $173.61 $1.05 Million - $1.11 Million
-6,401 Reduced 21.47%
23,408 $3.96 Million
Q3 2019

Nov 04, 2019

SELL
$159.77 - $178.1 $82,441 - $91,899
-516 Reduced 1.7%
29,809 $5.01 Million
Q2 2019

Aug 05, 2019

SELL
$144.16 - $172.9 $3.07 Million - $3.68 Million
-21,303 Reduced 41.26%
30,325 $5.24 Million
Q1 2019

May 01, 2019

SELL
$123.7 - $156.3 $91,414 - $115,505
-739 Reduced 1.41%
51,628 $7.9 Million
Q4 2018

Feb 11, 2019

SELL
$120.82 - $174.09 $12.9 Million - $18.6 Million
-107,056 Reduced 67.15%
52,367 $6.62 Million
Q3 2018

Nov 08, 2018

SELL
$167.67 - $188.27 $1.02 Million - $1.14 Million
-6,075 Reduced 3.67%
159,423 $27.7 Million
Q2 2018

Aug 07, 2018

SELL
$160.33 - $189.41 $3.75 Million - $4.43 Million
-23,412 Reduced 12.39%
165,498 $29.7 Million
Q1 2018

May 09, 2018

SELL
$161.53 - $178.11 $3.13 Million - $3.45 Million
-19,356 Reduced 9.29%
188,910 $30.6 Million
Q4 2017

Feb 09, 2018

BUY
$147.99 - $163.95 $251,139 - $278,223
1,697 Added 0.82%
208,266 $33.6 Million
Q3 2017

Nov 09, 2017

BUY
$149.47 - $160.56 $30.9 Million - $33.2 Million
206,569
206,569 $31.3 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.3B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.